Skip to main content

This is a new service - your feedback will help us to improve it.

Changes to dashboard update frequency over the festive period

Some of the metrics will be updated on Wednesday 24 December at 2pm. The dashboard will not be updated the following week commencing Monday 29 December. Normal updates will resume for all metrics in the new year on Thursday 8 January at 4pm. More info.

BackEntry title:

Hepatitis B latest mortality rate 100,000 population

Last updated on Thursday, 20 November 2025 at 03:12pm

Summary

Topic
Hepatitis-B
Category
headline
API name
hepatitis-b_headline_deaths

Rationale

This metric shows the number of deaths from hepatitis B related end stage liver disease (ESLD) and/or hepatocellular carcinoma (HCC). Monitoring hepatitis B-related mortality helps to monitor the impacts of whether individuals living with hepatitis B are promptly diagnosed, engaged with care, and have access to treatment when eligible. The WHO mortality target to demonstrate hepatitis B elimination is 4 per 100,000 or fewer deaths related to hepatitis B each year.

Methodology

The upper bound links data from national mortality records where the cause of death is recorded as ESLD and/or HCC or hepatitis B is recorded to hospital admissions data where ESLD and/or HCC or hepatitis B are recorded and laboratory diagnosis data for hepatitis B to yield a maximum number of deaths attributable to hepatitis B related ESLD and/or HCC.

Rates are calculated per 100,000 population using Office for National Statistics (ONS) population estimates.

Caveats

Some deaths linked to hepatitis B may not be accurately recorded. The data is presented as an upper bound and the true number of deaths is expected to be lower than this. The lower bound is presented elsewhere on the dashboard.

Hepatitis B related end-stage liver disease is defined by codes or text entries for ascites, bleeding oesophageal varices, hepato-renal syndrome, hepatic encephalopathy, or hepatic failure.

Back to top